The US Food and Drug Administration (FDA) has approved KalVista Pharmaceuticals' Ekterly (sebetralstat) as the first and only ...

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

While mom was alive, we thanked God for the time she spent with us. Her life was much more interesting and fascinating than I ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

A man accused of assaulting an Army veteran during a political protest is facing a felony charge, the Lincoln County District ...

After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...

A 77-year-old man, from Vermont, died while trying to rescue a turtle from the southbound lanes of I-95 on Sunday.

Ekterly comes in the form of a 300 mg tablet. The recommended dosage is 600 mg split into two doses taken at the earliest sign of an attack, according to the prescribing information. Additional ...

COLBERT, Wash. -- A man was hit and killed by an oncoming vehicle when he ran a stop sign in Colbert Sunday. According to ...

The Douglas County Sheriff’s Office is looking for a pair of suspects accused of stealing an elderly woman’s purse in ...

Two alleged fraudsters accused of swindling an elderly woman out of tens of thousands of dollars in cash have been arrested ...

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.